Fund Overview of Iti Pharma And Healthcare Fund Direct - Idcw
-
₹235.7 CrAUM
-
₹17.57NAV
-
0.47%Expense Ratio
-
EquityFund Category
Returns of Iti Pharma And Healthcare Fund Direct - Idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 0.68% | NA | 6.12% |
| 6 Months | 11.66% | NA | 12.92% |
| 1 Year | -0.91% | -0.91% | 6.04% |
| 2 Years | 56.02% | 24.91% | 24.93% |
| 3 Years | 84.83% | 22.72% | 25.71% |
Asset Allocation
equities
98.31%other assets or cash equivalents
1.69%Iti Pharma And Healthcare Fund Direct - Idcw is one Equity mutual fund offered by ITI Mutual Fund. Launched on 08 Nov 2021, the fund aims Capital appreciation over long term. Investments in equity and equity related securities of companies engaged in Pharma and Healthcare. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. It manages assets worth ₹235.7 crore as on Thu Jul 31, 2025. The expense ratio stands at 0.47%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Iti Pharma And Healthcare Fund Direct - Idcw
The portfolio allocation consists of 98.31% in equities, 1.69% in other assets or cash equivalents. Managed by Rohan Korde, it has delivered a return of -0.91% in the last year, a total return since inception of 15.79%.
Key Metrics of Iti Pharma And Healthcare Fund Direct - Idcw
-
Standard Deviation15.60%
-
Sharpe Ratio0.99%
-
Alpha-0.66%
-
Beta0.95%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from ITI Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Iti Pharma And Healthcare Fund Regular - Growth
|
₹236 | -1.86% | -1.16% | 0.66% | -1.60% | 19.31% |
|
Iti Pharma And Healthcare Fund Direct - Growth
|
₹236 | -1.70% | -0.68% | 1.63% | 0.27% | 21.65% |
|
Iti Pharma And Healthcare Fund Regular - Idcw
|
₹236 | -1.86% | -1.16% | 0.66% | -1.60% | 19.31% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.93% | ₹25.75 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.96% | ₹25.51 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.96% | ₹25.51 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.62% | ₹24.06 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.62% | ₹24.06 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.97% | ₹20.89 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.97% | ₹20.89 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.68% | ₹20.45 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.79% | ₹17.64 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.79% | ₹17.64 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.35% | ₹14.80 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.35% | ₹14.80 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.12% | ₹14.42 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.66% | ₹13.33 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.71% | ₹13.29 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.71% | ₹13.29 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.81% | ₹13.17 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.81% | ₹13.17 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.70% | ₹12.90 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.70% | ₹12.90 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 5.06% | ₹11.45 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 5.06% | ₹11.45 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 4.66% | ₹10.98 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.58% | ₹10.80 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.51% | ₹10.51 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.51% | ₹10.51 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.59% | ₹10.40 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.59% | ₹10.40 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 4.43% | ₹10.33 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 4.43% | ₹10.33 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.13% | ₹9.35 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.13% | ₹9.35 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.98% | ₹9.26 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.98% | ₹9.26 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.66% | ₹8.62 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.70% | ₹8.61 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.70% | ₹8.61 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.62% | ₹8.44 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.62% | ₹8.44 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.51% | ₹8.26 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.62% | ₹8.20 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.62% | ₹8.20 Cr |
| Lupin Ltd | Healthcare | 3.46% | ₹8.14 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.45% | ₹7.80 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.45% | ₹7.80 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.19% | ₹7.53 Cr |
| Cipla Ltd | Healthcare | 3.07% | ₹7.16 Cr |
| Cipla Ltd | Healthcare | 3.07% | ₹7.16 Cr |
| Lupin Ltd | Healthcare | 3.04% | ₹7.08 Cr |
| Lupin Ltd | Healthcare | 3.04% | ₹7.08 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.97% | ₹6.99 Cr |
| Lupin Ltd | Healthcare | 3.04% | ₹6.89 Cr |
| Lupin Ltd | Healthcare | 3.04% | ₹6.89 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.95% | ₹6.86 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.95% | ₹6.86 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.98% | ₹6.76 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.98% | ₹6.76 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.93% | ₹6.63 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.93% | ₹6.63 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.82% | ₹6.55 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.82% | ₹6.55 Cr |
| Wockhardt Ltd | Healthcare | 2.76% | ₹6.51 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.66% | ₹6.27 Cr |
| Wockhardt Ltd | Healthcare | 2.76% | ₹6.24 Cr |
| Wockhardt Ltd | Healthcare | 2.76% | ₹6.24 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.57% | ₹5.99 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.57% | ₹5.99 Cr |
| Abbott India Ltd | Healthcare | 2.47% | ₹5.81 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.57% | ₹5.81 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.57% | ₹5.81 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.45% | ₹5.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.45% | ₹5.54 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.24% | ₹5.28 Cr |
| Wockhardt Ltd | Healthcare | 2.27% | ₹5.28 Cr |
| Wockhardt Ltd | Healthcare | 2.27% | ₹5.28 Cr |
| Abbott India Ltd | Healthcare | 2.20% | ₹5.13 Cr |
| Abbott India Ltd | Healthcare | 2.20% | ₹5.13 Cr |
| Cipla Ltd | Healthcare | 2.21% | ₹5.00 Cr |
| Cipla Ltd | Healthcare | 2.21% | ₹5.00 Cr |
| Abbott India Ltd | Healthcare | 2.19% | ₹4.95 Cr |
| Abbott India Ltd | Healthcare | 2.19% | ₹4.95 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 1.77% | ₹4.13 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 1.77% | ₹4.13 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 1.79% | ₹4.05 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 1.79% | ₹4.05 Cr |
| Sumitomo Chemical India Ltd | Materials | 1.71% | ₹4.03 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.73% | ₹4.03 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.73% | ₹4.03 Cr |
| Net Receivables | Unspecified | 1.69% | ₹3.95 Cr |
| Net Receivables | Unspecified | 1.69% | ₹3.95 Cr |
| Laurus Labs Ltd | Healthcare | 1.69% | ₹3.95 Cr |
| Laurus Labs Ltd | Healthcare | 1.69% | ₹3.95 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 1.66% | ₹3.92 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.73% | ₹3.91 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.73% | ₹3.91 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.56% | ₹3.68 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.53% | ₹3.57 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.53% | ₹3.57 Cr |
| Net Receivables | Unspecified | 1.47% | ₹3.44 Cr |
| Net Receivables | Unspecified | 1.47% | ₹3.44 Cr |
| Fdc Ltd | Healthcare | 1.44% | ₹3.40 Cr |
| Fdc Ltd | Healthcare | 1.40% | ₹3.27 Cr |
| Fdc Ltd | Healthcare | 1.40% | ₹3.27 Cr |
| Granules India Ltd | Healthcare | 1.38% | ₹3.26 Cr |
| Sumitomo Chemical India Ltd | Materials | 1.42% | ₹3.21 Cr |
| Sumitomo Chemical India Ltd | Materials | 1.42% | ₹3.21 Cr |
| Fdc Ltd | Healthcare | 1.39% | ₹3.14 Cr |
| Fdc Ltd | Healthcare | 1.39% | ₹3.14 Cr |
| Sumitomo Chemical India Ltd | Materials | 1.35% | ₹3.14 Cr |
| Sumitomo Chemical India Ltd | Materials | 1.35% | ₹3.14 Cr |
| Laurus Labs Ltd | Healthcare | 1.31% | ₹3.08 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.30% | ₹3.07 Cr |
| Net Receivables | Unspecified | 1.29% | ₹3.04 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹3.01 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹3.01 Cr |
| Sagility India Ltd. | Industrials | 1.27% | ₹3.00 Cr |
| Laurus Labs Ltd | Healthcare | 1.31% | ₹2.97 Cr |
| Laurus Labs Ltd | Healthcare | 1.31% | ₹2.97 Cr |
| Sbi Life Insurance Company Ltd | Financial | 1.25% | ₹2.90 Cr |
| Sbi Life Insurance Company Ltd | Financial | 1.25% | ₹2.90 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.23% | ₹2.86 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.23% | ₹2.86 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.22% | ₹2.85 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.22% | ₹2.85 Cr |
| Biocon Ltd | Healthcare | 1.21% | ₹2.82 Cr |
| Biocon Ltd | Healthcare | 1.21% | ₹2.82 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.19% | ₹2.78 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.19% | ₹2.78 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.19% | ₹2.76 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.19% | ₹2.76 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.16% | ₹2.74 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.21% | ₹2.73 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.21% | ₹2.73 Cr |
| Orchid Pharma Ltd | Healthcare | 1.14% | ₹2.68 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.13% | ₹2.67 Cr |
| Sbi Life Insurance Company Ltd | Financial | 1.17% | ₹2.66 Cr |
| Sbi Life Insurance Company Ltd | Financial | 1.17% | ₹2.66 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.17% | ₹2.65 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.17% | ₹2.65 Cr |
| Orchid Pharma Ltd | Healthcare | 1.13% | ₹2.63 Cr |
| Orchid Pharma Ltd | Healthcare | 1.13% | ₹2.63 Cr |
| Piramal Pharma Ltd | Healthcare | 1.13% | ₹2.62 Cr |
| Piramal Pharma Ltd | Healthcare | 1.13% | ₹2.62 Cr |
| Orchid Pharma Ltd | Healthcare | 1.12% | ₹2.55 Cr |
| Orchid Pharma Ltd | Healthcare | 1.12% | ₹2.55 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.06% | ₹2.50 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.05% | ₹2.47 Cr |
| Navin Fluorine International Ltd | Materials | 1.05% | ₹2.47 Cr |
| Supriya Lifescience Ltd | Healthcare | 1.03% | ₹2.43 Cr |
| Standard Glass Lining Technology Ltd. | Industrials | 1.05% | ₹2.43 Cr |
| Standard Glass Lining Technology Ltd. | Industrials | 1.05% | ₹2.43 Cr |
| Supriya Lifescience Ltd | Healthcare | 1.07% | ₹2.43 Cr |
| Supriya Lifescience Ltd | Healthcare | 1.07% | ₹2.43 Cr |
| Strides Pharma Science Ltd | Healthcare | 1.02% | ₹2.41 Cr |
| Cipla Ltd | Healthcare | 1.02% | ₹2.40 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.98% | ₹2.32 Cr |
| Standard Glass Lining Technology Ltd. | Industrials | 1.02% | ₹2.31 Cr |
| Standard Glass Lining Technology Ltd. | Industrials | 1.02% | ₹2.31 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.02% | ₹2.31 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.02% | ₹2.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.99% | ₹2.30 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.99% | ₹2.30 Cr |
| Srf Ltd | Materials | 0.97% | ₹2.28 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 0.97% | ₹2.28 Cr |
| Sagility India Ltd. | Industrials | 0.97% | ₹2.20 Cr |
| Sagility India Ltd. | Industrials | 0.97% | ₹2.20 Cr |
| Poly Medicure Ltd | Healthcare | 0.93% | ₹2.16 Cr |
| Poly Medicure Ltd | Healthcare | 0.93% | ₹2.16 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.93% | ₹2.10 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.93% | ₹2.10 Cr |
| Poly Medicure Ltd | Healthcare | 0.93% | ₹2.10 Cr |
| Poly Medicure Ltd | Healthcare | 0.93% | ₹2.10 Cr |
| Linde India Ltd | Materials | 0.87% | ₹2.06 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 0.86% | ₹2.01 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 0.86% | ₹2.01 Cr |
| Standard Glass Lining Technology Ltd. | Industrials | 0.84% | ₹1.97 Cr |
| Supriya Lifescience Ltd | Healthcare | 0.85% | ₹1.97 Cr |
| Supriya Lifescience Ltd | Healthcare | 0.85% | ₹1.97 Cr |
| Linde India Ltd | Materials | 0.86% | ₹1.96 Cr |
| Linde India Ltd | Materials | 0.86% | ₹1.96 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 0.86% | ₹1.94 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 0.86% | ₹1.94 Cr |
| Srf Ltd | Materials | 0.84% | ₹1.89 Cr |
| Srf Ltd | Materials | 0.84% | ₹1.89 Cr |
| Linde India Ltd | Materials | 0.81% | ₹1.89 Cr |
| Linde India Ltd | Materials | 0.81% | ₹1.89 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.82% | ₹1.87 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.82% | ₹1.87 Cr |
| Sai Life Sciences Ltd. | Healthcare | 0.77% | ₹1.82 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.76% | ₹1.79 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.75% | ₹1.75 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.75% | ₹1.75 Cr |
| Biocon Ltd | Healthcare | 0.74% | ₹1.73 Cr |
| Sbi Life Insurance Company Ltd | Financial | 0.73% | ₹1.73 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 0.72% | ₹1.71 Cr |
| Upl Ltd | Materials | 0.72% | ₹1.67 Cr |
| Upl Ltd | Materials | 0.72% | ₹1.67 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.70% | ₹1.64 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.70% | ₹1.64 Cr |
| Upl Ltd | Materials | 0.69% | ₹1.63 Cr |
| Navin Fluorine International Ltd | Materials | 0.72% | ₹1.62 Cr |
| Navin Fluorine International Ltd | Materials | 0.72% | ₹1.62 Cr |
| Upl Ltd | Materials | 0.67% | ₹1.52 Cr |
| Upl Ltd | Materials | 0.67% | ₹1.52 Cr |
| Biocon Ltd | Healthcare | 0.67% | ₹1.51 Cr |
| Biocon Ltd | Healthcare | 0.67% | ₹1.51 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.63% | ₹1.42 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.63% | ₹1.42 Cr |
| Syngene International Ltd | Healthcare | 0.52% | ₹1.23 Cr |
| Piramal Pharma Ltd | Healthcare | 0.51% | ₹1.15 Cr |
| Piramal Pharma Ltd | Healthcare | 0.51% | ₹1.15 Cr |
| Syngene International Ltd | Healthcare | 0.48% | ₹1.12 Cr |
| Syngene International Ltd | Healthcare | 0.48% | ₹1.12 Cr |
| Syngene International Ltd | Healthcare | 0.47% | ₹1.07 Cr |
| Syngene International Ltd | Healthcare | 0.47% | ₹1.07 Cr |
| Ttk Healthcare Ltd | Healthcare | 0.31% | ₹0.72 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
Iti Pharma And Healthcare Fund Direct - Idcw
What is the current AUM of Iti Pharma And Healthcare Fund Direct - Idcw?
As of Thu Jul 31, 2025, Iti Pharma And Healthcare Fund Direct - Idcw manages assets worth ₹235.7 crore
How has Iti Pharma And Healthcare Fund Direct - Idcw performed recently?
- 3 Months: 0.68%
- 6 Months: 11.66%
What is the long-term performance of Iti Pharma And Healthcare Fund Direct - Idcw?
- 3 Years CAGR: 22.72%
- Since Inception: 15.79%
What is the portfolio composition of Iti Pharma And Healthcare Fund Direct - Idcw?
Equity: 98.31%, Others: 1.69%.
Who manages Iti Pharma And Healthcare Fund Direct - Idcw?
Iti Pharma And Healthcare Fund Direct - Idcw is managed by Rohan Korde from ITI Mutual Fund.
What is the market-cap allocation of Iti Pharma And Healthcare Fund Direct - Idcw?
Large Cap: 49.18%, Mid Cap: 21.57%, Small Cap: 29.24%.
Which are the top companies Iti Pharma And Healthcare Fund Direct - Idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 10.93% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.96% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.96% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.62% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.62% of the fund's portfolio
Which are the major sectors Iti Pharma And Healthcare Fund Direct - Idcw focuses on?
- Healthcare – 457.80% of the fund's portfolio
- Materials – 20.83% of the fund's portfolio
- Industrials – 8.19% of the fund's portfolio
- Unspecified – 7.61% of the fund's portfolio
- Financial – 5.57% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


